Filter posts

FDA Week: For Biologics, A Name Isn't Just A Name (Jim Greenwood op-ed)

What is in a name? Names help make medicinal products more easily distinguishable by doctors, …

National Black HIV/AIDS Awareness Day

In the United States, more than one million people are infected with HIV, with an …

Cancer Insurance Checklist: Guía de Cobertura Médica para Personas con Cáncer

As the world marks World Cancer Day and the U.S. continues to implement the Affordable …

BIO Responds to GPhA Citizen Petition on Biosimilars Naming

Last September, the Generic Pharmaceutical Association (GPhA) filed a Citizen Petition with the FDA, requesting …

Life Science Leader on TransCelerate’s Efforts to Modernize Drug Development

Life Science Leader’s Rob Wright has a great profile on TransCelerate BioPharma and their efforts …

2013 Novel Drug Approvals

The FDA approved 24 novel drugs last year by our count, in line with average …

IPAB: Bad Medicine for Patient Care

The Independent Payment Advisory Board is bad medicine for patient care, deficit reduction and containing …

NPR’s Shots Blog: Vaccine Fears Fueled The Resurgence Of Preventable Diseases

This past weekend, Michaeleen Doucleff at NPR’s Shots blog shared a fascinating but disturbing map …

Young Invincibles Still Need Flu Shot

Last Friday, the CDC reported that 35 states are seeing widespread cases of influenza. Young …

BIO Joins Partners for Healthy Dialogues

The Biotechnology Industry Organization (BIO) recently joined the Partners for Healthy Dialogues effort. Dialogues+ had …